Global Aurora Kinase C Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Aurora Kinase C
- 1.1 Definition of Aurora Kinase C
- 1.2 Aurora Kinase C Segment by Type
- 1.2.1 Global Aurora Kinase C Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 AMG-900
- 1.2.3 Danusertib
- 1.2.4 Ilorasertib
- 1.2.5 NMI-900
- 1.2.6 SAR-156497
- 1.2.7 Others
- 1.3 Aurora Kinase C Segment by Applications
- 1.3.1 Global Aurora Kinase C Consumption Comparison by Applications (2014-2025)
- 1.3.2 Solid Tumor
- 1.3.3 Non-Small Cell Lung Cancer
- 1.3.4 Acute Lymphocytic Leukemia
- 1.3.5 Others
- 1.4 Global Aurora Kinase C Overall Market
- 1.4.1 Global Aurora Kinase C Revenue (2014-2025)
- 1.4.2 Global Aurora Kinase C Production (2014-2025)
- 1.4.3 North America Aurora Kinase C Status and Prospect (2014-2025)
- 1.4.4 Europe Aurora Kinase C Status and Prospect (2014-2025)
- 1.4.5 China Aurora Kinase C Status and Prospect (2014-2025)
- 1.4.6 Japan Aurora Kinase C Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Aurora Kinase C Status and Prospect (2014-2025)
- 1.4.8 India Aurora Kinase C Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Aurora Kinase C
- 2.3 Manufacturing Process Analysis of Aurora Kinase C
- 2.4 Industry Chain Structure of Aurora Kinase C
3 Development and Manufacturing Plants Analysis of Aurora Kinase C
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Aurora Kinase C Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Aurora Kinase C
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Aurora Kinase C Production and Capacity Analysis
- 4.2 Aurora Kinase C Revenue Analysis
- 4.3 Aurora Kinase C Price Analysis
- 4.4 Market Concentration Degree
5 Aurora Kinase C Regional Market Analysis
- 5.1 Aurora Kinase C Production by Regions
- 5.1.1 Global Aurora Kinase C Production by Regions
- 5.1.2 Global Aurora Kinase C Revenue by Regions
- 5.2 Aurora Kinase C Consumption by Regions
- 5.3 North America Aurora Kinase C Market Analysis
- 5.3.1 North America Aurora Kinase C Production
- 5.3.2 North America Aurora Kinase C Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Aurora Kinase C Import and Export
- 5.4 Europe Aurora Kinase C Market Analysis
- 5.4.1 Europe Aurora Kinase C Production
- 5.4.2 Europe Aurora Kinase C Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Aurora Kinase C Import and Export
- 5.5 China Aurora Kinase C Market Analysis
- 5.5.1 China Aurora Kinase C Production
- 5.5.2 China Aurora Kinase C Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Aurora Kinase C Import and Export
- 5.6 Japan Aurora Kinase C Market Analysis
- 5.6.1 Japan Aurora Kinase C Production
- 5.6.2 Japan Aurora Kinase C Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Aurora Kinase C Import and Export
- 5.7 Southeast Asia Aurora Kinase C Market Analysis
- 5.7.1 Southeast Asia Aurora Kinase C Production
- 5.7.2 Southeast Asia Aurora Kinase C Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Aurora Kinase C Import and Export
- 5.8 India Aurora Kinase C Market Analysis
- 5.8.1 India Aurora Kinase C Production
- 5.8.2 India Aurora Kinase C Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Aurora Kinase C Import and Export
6 Aurora Kinase C Segment Market Analysis (by Type)
- 6.1 Global Aurora Kinase C Production by Type
- 6.2 Global Aurora Kinase C Revenue by Type
- 6.3 Aurora Kinase C Price by Type
7 Aurora Kinase C Segment Market Analysis (by Application)
- 7.1 Global Aurora Kinase C Consumption by Application
- 7.2 Global Aurora Kinase C Consumption Market Share by Application (2014-2019)
8 Aurora Kinase C Major Manufacturers Analysis
- 8.1 AbbVie Inc
- 8.1.1 AbbVie Inc Aurora Kinase C Production Sites and Area Served
- 8.1.2 AbbVie Inc Product Introduction, Application and Specification
- 8.1.3 AbbVie Inc Aurora Kinase C Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Amgen Inc
- 8.2.1 Amgen Inc Aurora Kinase C Production Sites and Area Served
- 8.2.2 Amgen Inc Product Introduction, Application and Specification
- 8.2.3 Amgen Inc Aurora Kinase C Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Cielo Therapeutics Inc
- 8.3.1 Cielo Therapeutics Inc Aurora Kinase C Production Sites and Area Served
- 8.3.2 Cielo Therapeutics Inc Product Introduction, Application and Specification
- 8.3.3 Cielo Therapeutics Inc Aurora Kinase C Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Sanofi
- 8.4.1 Sanofi Aurora Kinase C Production Sites and Area Served
- 8.4.2 Sanofi Product Introduction, Application and Specification
- 8.4.3 Sanofi Aurora Kinase C Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
9 Development Trend of Analysis of Aurora Kinase C Market
- 9.1 Global Aurora Kinase C Market Trend Analysis
- 9.1.1 Global Aurora Kinase C Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Aurora Kinase C Regional Market Trend
- 9.2.1 North America Aurora Kinase C Forecast 2019-2025
- 9.2.2 Europe Aurora Kinase C Forecast 2019-2025
- 9.2.3 China Aurora Kinase C Forecast 2019-2025
- 9.2.4 Japan Aurora Kinase C Forecast 2019-2025
- 9.2.5 Southeast Asia Aurora Kinase C Forecast 2019-2025
- 9.2.6 India Aurora Kinase C Forecast 2019-2025
- 9.3 Aurora Kinase C Market Trend (Product Type)
- 9.4 Aurora Kinase C Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Aurora Kinase C Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Aurora Kinase C market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Aurora Kinase C volume and value at global level, regional level and company level. From a global perspective, this report represents overall Aurora Kinase C market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Aurora Kinase C in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Aurora Kinase C manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie Inc
Amgen Inc
Cielo Therapeutics Inc
Sanofi
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
AMG-900
Danusertib
Ilorasertib
NMI-900
SAR-156497
Others
Segment by Application
Solid Tumor
Non-Small Cell Lung Cancer
Acute Lymphocytic Leukemia
Others